Display options
Share it on

Antimicrob Agents Chemother. 2007 Jun;51(6):2070-7. doi: 10.1128/AAC.01472-06. Epub 2007 Apr 16.

Polyamine effects on antibiotic susceptibility in bacteria.

Antimicrobial agents and chemotherapy

Dong-Hyeon Kwon, Chung-Dar Lu

Affiliations

  1. Department of Biology, Georgia State University, 24 Peachtree Center Avenue, Atlanta, GA 30303, USA.

PMID: 17438056 PMCID: PMC1891406 DOI: 10.1128/AAC.01472-06

Abstract

Biogenic polyamines (e.g., spermidine and spermine) are a group of essential polycationic compounds found in all living cells. The effects of spermine and spermidine on antibiotic susceptibility were examined with gram-negative Escherichia coli and Salmonella enterica serovar Typhimurium bacteria and clinical isolates of Pseudomonas aeruginosa and with gram-positive Staphylococcus aureus bacteria, including methicillin-resistant S. aureus (MRSA). Exogenous spermine exerted a dose-dependent inhibition effect on the growth of E. coli, S. enterica serovar Typhimurium, and S. aureus but not P. aeruginosa, as depicted by MIC and growth curve measurements. While the MICs of polymyxin and ciprofloxacin were in general increased by exogenous spermine and spermidine in P. aeruginosa, this adverse effect was not observed in enteric bacteria and S. aureus. It was found that spermine and spermidine can decrease the MICs of beta-lactam antibiotics in all strains as well as other types of antibiotics in a strain-dependent manner. Significantly, the MICs of oxacillin for MRSA Mu50 and N315 were decreased more than 200-fold in the presence of spermine, and this effect of spermine was retained when assessed in the presence of divalent ions (magnesium or calcium; 3 mM) or sodium chloride (150 mM). The effect of spermine on the sensitization of P. aeruginosa and MRSA to antibiotics was further demonstrated by population analysis and time-killing assays. The results of checkerboard assays with E. coli and S. aureus indicated a strong synergistic effect of spermine in combination with beta-lactams and chloramphenicol. The decreased MICs of beta-lactams implied that the possible blockage of outer membrane porins by exogenous spermine or spermidine did not play a crucial role in most cases. In contrast, only the MIC of imipenem against P. aeruginosa was increased by exogenous spermine and spermidine, and this resistance effect was abolished in a mutant strain devoid of the outer membrane porin OprD. In E. coli, the MICs of carbenicillin, chloramphenicol, and tetracycline were decreased in two acrA mutants devoid of a major efflux pump, AcrAB. However, retention of the spermine effect on antibiotic susceptibility in two acrA mutants of E. coli suggested that the AcrAB efflux pump was not the target for a synergistic effect by spermine and antibiotics and ruled out the hypothesis of spermine serving as an efflux pump inhibitor in this organism. In summary, this interesting finding of the effect of spermine on antibiotic susceptibility provides the basis for a new potential approach against drug-resistant pathogens by use of existing beta-lactam antibiotics.

References

  1. Antimicrob Agents Chemother. 1992 Sep;36(9):2046-8 - PubMed
  2. Am J Med. 2006 Nov;119(11):943-51 - PubMed
  3. Biotechniques. 1993 Nov;15(5):831-4 - PubMed
  4. Science. 1994 Apr 15;264(5157):382-8 - PubMed
  5. Trends Biochem Sci. 1994 Mar;19(3):119-23 - PubMed
  6. J Bacteriol. 1996 Jul;178(13):3715-21 - PubMed
  7. J Bacteriol. 1996 Oct;178(20):5853-9 - PubMed
  8. Antimicrob Agents Chemother. 1996 Aug;40(8):1914-8 - PubMed
  9. Amino Acids. 2004 Dec;27(3-4):347-58 - PubMed
  10. Ann Emerg Med. 2005 Mar;45(3):311-20 - PubMed
  11. Mol Microbiol. 1999 Oct;34(2):305-16 - PubMed
  12. Biochem Biophys Res Commun. 2000 May 19;271(3):559-64 - PubMed
  13. Microbiology. 2000 Oct;146 ( Pt 10):2543-54 - PubMed
  14. Int J Antimicrob Agents. 2000 Nov;16 Suppl 1:S3-10 - PubMed
  15. Cell Mol Life Sci. 1999 Nov 30;56(9-10):764-70 - PubMed
  16. Antimicrob Agents Chemother. 2001 Feb;45(2):480-4 - PubMed
  17. Annu Rev Microbiol. 2002;56:17-38 - PubMed
  18. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2261-5 - PubMed
  19. Mol Microbiol. 2003 Oct;50(1):205-17 - PubMed
  20. Arch Biochem Biophys. 2003 Oct 15;418(2):125-32 - PubMed
  21. Clin Chim Acta. 2004 Jun;344(1-2):23-35 - PubMed
  22. J Biol Chem. 2004 Sep 24;279(39):40802-6 - PubMed
  23. Gene. 1986;50(1-3):133-40 - PubMed
  24. J Bacteriol. 1990 Jun;172(6):3496-9 - PubMed
  25. J Bacteriol. 1991 May;173(9):3000-9 - PubMed
  26. Antimicrob Agents Chemother. 1992 Mar;36(3):533-9 - PubMed
  27. J Biochem. 2006 Jan;139(1):11-6 - PubMed
  28. J Antimicrob Chemother. 2006 Feb;57(2):339-43 - PubMed
  29. Biochem Pharmacol. 2006 Mar 30;71(7):910-8 - PubMed
  30. Ann Intern Med. 2006 Mar 7;144(5):309-17 - PubMed
  31. Antimicrob Agents Chemother. 2006 May;50(5):1615-22 - PubMed
  32. Antimicrob Agents Chemother. 2006 May;50(5):1623-7 - PubMed
  33. N Engl J Med. 2006 Aug 17;355(7):666-74 - PubMed
  34. Antimicrob Agents Chemother. 2006 Oct;50(10):3424-34 - PubMed
  35. J Bacteriol. 1993 Oct;175(19):6299-313 - PubMed

Substances

MeSH terms

Publication Types